Select Medical
SEM was delisted on the 30th of June, 2026.
217 hedge funds and large institutions have $2.39B invested in Select Medical in 2019 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 72 increasing their positions, 66 reducing their positions, and 11 closing their positions.
31,287% more call options, than puts
Call options by funds: $12.2M | Put options by funds: $39K
345% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 11
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
40% more capital invested
Capital invested by funds: $1.71B → $2.39B (+$682M)
16% more funds holding
Funds holding: 187 → 217 (+30)
9% more repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 66
0.34% more ownership
Funds ownership: 141.43% → 141.77% (+0.34%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$12.6M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$12.5M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$8.86M |
| 4 |
Millennium Management
New York
|
+$7.48M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$6.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$26.3M |
| 2 |
TCM
TimesSquare Capital Management
New York
|
-$24.6M |
| 3 |
DM
Deerfield Management
New York
|
-$18.4M |
| 4 |
HM
HealthCor Management
New York
|
-$13.7M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$10.3M |
SEM Hedge Fund Activity: Q4 2019 in Review
217 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q4 2019, worth a combined $2.39B — up 40% from $1.71B a quarter earlier.
Buyers outnumbered sellers: 49 funds opened new SEM positions and 11 closed out — a net gain of 38 holders — while 72 added to existing stakes and 66 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $12.6M. The largest seller was T. Rowe Price Associates, cutting an estimated $26.3M.
- 217 institutional investors held Select Medical (SEM) as of Q4 2019, up from 187 in Q3 2019.
- Funds reported $2.39B of Select Medical stock for Q4 2019, up 40% quarter-over-quarter.
- 49 funds opened new Select Medical positions in Q4 2019 and 11 closed out, a net change of +38 holders.
- The largest Select Medical buyer in Q4 2019 was Renaissance Technologies, an estimated $12.6M added.
- The largest Select Medical seller in Q4 2019 was T. Rowe Price Associates, an estimated $26.3M sold.
Based on aggregated 13F filings for Q4 2019.